Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Contributed by: Business Wire

Logo

Tags

Research

Mental Health

Finance

Banking

Clinical Trials

Professional Services

Biotechnology

Pharmaceutical

Health

Science

Inducement Grants

More Like This

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

Compass Pathways Announces Pricing of $150 Million Public Offering

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways Launches Proposed $150.0 Million Public Offering

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Compass Pathways to Participate in Four Investor Conferences in September

Compass Pathways to Participate in Two Investor Conferences in December

Compass Pathways to Participate in Stifel 2025 Healthcare Conference